3d.FAB platform is the only French “Plateforme Technologique Innovante” dedicated to academic and private innovations through 3D, 4D and bioprinting, in the field of life science and healthcare. The platform is suported by the @Région AURA. The platform have expertise and facilities in the following areas: - Biochemistry, especially diagnosis with prototyping 3D lab-on-chip, novel materials for 3D medical devices, biocompatible polymers and cell-size 3D printing. - Regenerative medicine through dedicated living cells and tissues printers. - Simulation to create optimal liquid flow inside the 3D printed tissues. - Bioprocess for connective tissue maturation and vascularization. - Level 2 biofabrication laboratories equipped with state of the art bioprinters and bioreactors.
| Website | http://fabric-advanced-biology.univ-lyon1.fr |
| Revenue | $515.5 million |
| Employees | 12 (7 on RocketReach) |
| Founded | 2015 |
| Industry | Biotechnology |
| Keywords | Healthcare, 3d Printing, Research Platform, Bioprinting, Innovation Platform, Biomedical Engineering, Technology Platform, 3d Bioprinting, Additive Manufacturing, Tissue Engineering, Academic Research, Scientific Innovation, Rapid Prototyping, Regenerative Medicine, Private Research, Drug Discovery, Personalized Medicine |
| Competitors | HP, 3D Systems Corporation, Acuity Brands, Stratasys, Formlabs, Materialise, UltiMaker, Shapeways, Sculpteo - a brand of BASF, Zortrax S.A. +31 more (view full list) |
Looking for a particular 3d.FAB platform employee's phone or email?
The 3d.FAB platform annual revenue was $515.5 million in 2026.
Emma Petiot is the Director 3D Innovation Lab of 3d.FAB platform.
7 people are employed at 3d.FAB platform.